Japan Approves Worlds First iPS Therapies for Parkinsons, Heart Failure Conditional approval granted for Sumitomo Pharmas ...

Conditional genetics and single-embryo RNA-seq show that SETDB1 extinguishes the transient, retroelement-driven transcriptional programs of the totipotent two-cell state to facilitate the exit from ...

In a bid to treat blindness, Life Biosciences will try out potent cellular reprogramming technology on volunteers. When Elon Musk was at Davos last week, an interviewer asked him if he thought aging ...

Prostate cancer (PCa) is one of the most common malignant tumors among men worldwide. Following androgen deprivation therapy (ADT), the disease often progresses to castration-resistant prostate cancer ...

Magnetic nanoparticles engineered T cells inside living mice and guided them into solid tumors, achieving over 90% tumor inhibition where conventional immunotherapy fails. (Nanowerk Spotlight) ...

A recent review published in the journal Current Clinical Microbiology Reports discussed how modern lifestyle factors affect the microbiome. Changes in the metabolomic output and composition of the ...

Scientists at KAIST have found a way to turn a tumor’s own immune cells into powerful cancer fighters—right inside the body. Tumors are packed with macrophages, immune cells that should attack cancer ...

Viruses have spent billions of years perfecting the art of invading cells, hijacking their machinery and spreading with ruthless efficiency. Now researchers are turning that evolutionary expertise ...

As we age, we don’t recover from injury or illness like we did when we were young. But new research from UCSF has found gene regulators — proteins that turn genes on and off — that could restore the ...

Mechanical engineers at Duke University have developed solid building blocks whose mechanical properties can be programmed and reprogrammed on demand. By controlling whether tiny internal cells are ...